Rat model of down syndrome and method for producing same

US11825817B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11825817-B2
Application numberUS-201716337381-A
CountryUS
Kind codeB2
Filing dateSep 28, 2017
Priority dateSep 28, 2016
Publication dateNov 28, 2023
Grant dateNov 28, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In this application, the provided are: a Down syndrome rat model characterized in that a rat gene homologous to at least one gene present on a human chromosome 21 or fragment thereof is a trisomy and is transmittable to progeny; or a Down syndrome rat model characterized in that it comprises a human chromosome 21 or fragment thereof, or an exogenous rat chromosome or fragment thereof on which a rat gene homologous to the human chromosome 21 or fragment thereof is present, wherein at least one gene on the human chromosome 21 or fragment thereof or on the exogenous rat chromosome or fragment thereof is added to endogenous rat genes homologous to the at least gene so as to become a trisomy and to be transmittable to progeny: and a method for producing the Down syndrome rat model.

First claim

Opening claim text (preview).

The invention claimed is: 1. A genetically modified rat that models Down Syndrome, wherein at least 80% of tissues in the rat comprise a full length human chromosome 21, and the rat exhibits symptoms of Down Syndrome. 2. The genetically modified rat that models Down Syndrome of claim 1 , wherein the human chromosome 21 comprises DNA encoding a fluorescent protein. 3. A method for producing a genetically modified rat that models Down syndrome, the method comprising: a) fusing a microcell comprising a full-length human chromosome 21 with a male embryonic stem (ES) cell such that a chimeric ES cell comprising the full-length human chromosome 21 is obtained; b) introducing the chimeric ES cells obtained in step a) into a rat blastocyst or 8-cell embryo such that a chimeric embryo is obtained, c) transplanting the chimeric embryo obtained in step b) into a recipient female rat such that a chimeric male rat is obtained; d) inseminating a female rat with spermatids obtained from the chimeric male rat to produce a plurality of rat progeny; and e) selecting the genetically modified rat of claim 2 from the plurality of rat progeny produced in step (d). 4. The method according to claim 3 , wherein the human chromosome 21 comprises DNA encoding a fluorescent protein.

Assignees

Inventors

Classifications

  • Chimeric vertebrates, e.g. comprising exogenous cells · CPC title

  • Knock-in vertebrates, e.g. humanised vertebrates · CPC title

  • Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion {(monoclonal antibodies C07K16/00; apparatus for cell fusion C12M)} · CPC title

  • Animals modified by administration of exogenous cells · CPC title

  • Humanized animals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11825817B2 cover?
In this application, the provided are: a Down syndrome rat model characterized in that a rat gene homologous to at least one gene present on a human chromosome 21 or fragment thereof is a trisomy and is transmittable to progeny; or a Down syndrome rat model characterized in that it comprises a human chromosome 21 or fragment thereof, or an exogenous rat chromosome or fragment thereof on which a…
Who is the assignee on this patent?
Nat Univ Corp Tottori Univ, Trans Chromosomics Inc
What technology area does this patent fall under?
Primary CPC classification A01K67/0271. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).